Do you know that traders are currently enjoying using binary option trading? Binary options are options with a fixed return because this option only has 2 possible outcomes. A binary…
The newest episode of the AZ Big Podcast with Michael & Amy has officially dropped. Episode 149 features Elise Thorpe, principal at Marsh McLennan Agency (formerly Lovitt & Touché), who talks about…
Az Business and AZRE magazines announced the publications’ lists of the Most Influential Women in Arizona of 2024, including Haley Harrigan, shareholder at Gallagher & Kennedy. In celebration of the…
When I took on my first management role at LT (formerly LaneTerralever), a full-service marketing agency here in the Valley, I thought I knew what I was getting myself into.…
Ten years ago, many people made the West Valley their second, third or fourth choice when locating businesses and development, according to Jason Morris, founding partner of Withey Morris Baugh.…
Voice search technology is reshaping the way we use and interact with our gadgets. Now, you can simply talk to your smartphone, smart speaker, or car to get the information…
In the modern healthcare landscape, managing billing and revenue cycles can be enormous for healthcare providers. As technology advances and regulations evolve, navigating these complexities while maintaining high-quality patient care…
Today, the Biden-Harris Administration announced that the U.S. Department of Commerce and Amkor Technology, Inc. have signed a non-binding preliminary memorandum of terms (PMT) to provide up to $400 million…
Each year since 2012, Az Business magazine has selected its Most Influential Women in Arizona Business and featured them in the July issue. Based on nominations, women who have been…
Did you know that in the 1800s, getting injured on the job often meant you were out of luck? There was no safety net, no compensation for lost wages or…
For traders and investors, automated trading bots can be powerful tools to improve performance. Bots execute strategies with speed and precision impossible for humans. This gives traders an edge in…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, has presented groundbreaking results from its Phase IIb/III trial of blarcamesine (Anavex 2-73) for treatment of early Alzheimer’s disease at the 2024…
